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The Di(a+b-) phenotype is extremely rare among Caucacians and mostly confined to mongoloids. The clinical 
significance of anti-Dib is incompletely recognized. The authors report here a mild case of hemolytic disease 
of the fetus and newborn (HDFN) due to anti-Dib. The mother was Di(a+b-) with anti-Dib, which was detected 
by antenatal screening. She delivered a Di(a+b+) infant with a positive direct antiglobulin test and mild hemolytic 
disease. The infant was treated by phototherapy and subsequently recovered without the need for exchange 
transfusion. We suggest that the screening program as routine prenatal care is necessary. (Korean J Blood 
Transfus 2010;21:165-170)
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Introduction
  The Diego blood group mainly consists of 2 in-
dependent pairs of antigens, called Dia/Dib and 
Wra/Wrb.1) The Dia antigen is very rare in Cauca-
sians, but is relatively common in mongoloid popu-
lations, including South American Indians (7∼
54%), Chinese, Korean, and Japanese (5∼8%) 
populations.2) In contrast, the Dib antigen is common 
in all populations and the Di(a+b-) phenotype is 
almost exclusively found in mongoloid persons with 
a few other ethnic cases on record. Anti-Dib was 
first discovered in 1967 by Thompson and cowor-
kers while investigating the cause of a delayed 
hemolytic transfusion reaction. Its clinical significance 
is still not entirely known.
  There have been about 30 reported cases of 
hemolytic disease of the fetus and newborn (HDFN) 
due to anti-Dib, mostly in the Japanese population3)  
and three additional cases among Koreans have also 
been reported.4-6) We report a baby born to a Di 
(a+b-) Korean mother who suffered mild HDFN due 
to anti-Dib, while in the previous 3 cases of similar 
disease in Korea, anti-Dib had been found after 
HDFN occurred to an infant without antenatal scree-
ning for irregular antibodies. In the present study, 
anti-Dib on antenatal screening was observed, en-
abling the perinatal community occasion to prepare 
for the potential problem of HDFN and to secure 
compatible Di(b-) blood. Two units of autologous 
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blood were prepared by mother.
Case Report
  A 33-year-old Korean woman (gravida2, para1) 
presented in her second pregnancy. Anti-Dib was 
found antenatal through irregular antibody screening 
on IUP 15 weeks. The mother’s serum had a 
positive indirect antiglobulin test (IAT) (3+) and her 
red blood cells (RBCs) tested negative with direct 
antiglobulin test (DAT). Her serum also reacted with 
the entire panel of RBCs. Because of the suspicion 
of HDFN due to an antibody against a high-frequency 
red cell antigen, the mother’s red cells antigens were 
tested for Lub, k and Dia which can be the cause 
of HDFN. Her phenotype was found to be: Lu(b+), 
k(+), Di(a+). The Dib phenotyping was performed 
using a monoclonal anti-Dib antibody from the 
Japanese Red Cross Blood Center (Osaka, Japan), 
and Dib phenotype was negative. In the 36th week 
of gestation, her antibody titer came in at 256 with 
Di(a+b+) RBCs.
  A study of the maternal family showed the pre-
senting woman to be Di(a+b-), while her parents, a 
sister, a brother, and the baby were all Di(a+b+). Dia 
antigen was determined on maternal and familial 
RBCs by the transfusion research institute, Korean 
Red Cross (KRC); Dib antigen was determined on 
familial RBCs by cross-matching to the antiglobulin 
phase of mother’s serum. The antibody present in 
maternal serum did not react with Di(b-), O red cells, 
thus specifically confirming the maternal serum 
antibody to be anti-Dib.
  The presenting woman had a history of Cesarean 
sections, and, ten years prior, reported having re-
ceived RBC transfusion during such a surgical ope-
ration. Her previous newborn was healthy, although 
suffered some fetal respiratory difficulty at birth. In 
general, when antenatal patients with irregular anti-
bodies present, their husband should be promptly 
tested for the presence of relevant antigen. If found, 
physician should immediately determine the severity 
of such disease as can be caused by the presence 
of this antibody. Because frequencies of the Diego 
blood group phenotype in Koreans are, respectively, 
0.25% for Di(a+b-), 9.75% for Di(a+b+), and 90% 
for Di(a-b+),7) the authors presumed the paternal 
phenotype to be Di(b+).
  We also concluded that the fetus in this instance 
was at risk for HDFN, and that the perinatal needs 
of the mother might be severe, so we prepares Di(b-) 
blood for either exchange- or red cell-transfusion.
Since all family members’ RBCs (in toto) were po-
sitive for Dib antigen, baby’s mother donated her 
RBCs twice (at IUP 36 and IUP 37 weeks), so as 
to be prepared in the event that HDFN surfaced. 
Under the assumption that her baby might be group 
B, this would mean that the maternal blood with 
which we were dealing would, due to ABO incom-
patibility, automatically become in appropriate for 
exchange transfusion of the coming baby. So we 
requested KRC to procure compatible blood at least 
two days before delivery. Interestingly, among 600 
O+ blood units tested, we found only one (1) donor 
with group O red cells that proved antigen-negative 
for the mother’s anti-Dib antibody, yet which was at 
the same time was compatible by cross-matching 
with maternal plasma.
  At 38 weeks of gestation, a male baby was born 
by Cesarean section. The neonate’s and the mother’s 
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red cells typed B, RhD positive, and A, RhD posi-
tive, respectively. Neonatal red cells reacted posi-
tively (3+) in the DAT while the serum reacted 
positively (2+) in the IAT. Eluate from these red 
cells were reactive with the entire panel of red cells 
we’d tested, so we deduced anti-Dib in the neonate’s 
serum from the results mentioned above. Laboratory 
examination at birth showed a hemoglobin level of 
19.6 g/dL, reticulocyte count at 2.87%, and a biliru-
bin of 4.1 mg/dL. Bilirubin, in fact, rose up to 9.7 
mg/dL on the neonatal day two (ND2) (reference 
range of total bilitubin: 2∼6 mg/dL for 24 hr after 
birth, 6∼7 mg/dL for 48 hr, 4∼12 mg/dL for 3∼5 
day). There was no specific finding on peripheral 
blood smear. There was no hepatosplenomegaly nor 
neurologic abnormalities to be recorded or evaluated. 
Phototherapy was started on ND2, immediately after 
admission, and the patient remarkably recovered 
without the subsequent need for exchange transfu-
sion. Her newborn was discharged on the 6th day 
of life in good health without anemia.
Discussion
  It has been shown that Dib antigen is well developed 
on RBCs at birth and anti-Dib can contribute to 
severe jaundice in the presence of a Dib mismatch. 
Anti-Dib is usually formed during a previous pre-
gnancy characterized by mismatch, or typically after 
problematic blood transfusion. In the case under 
study here, this 33-year-old mother with a transfu-
sion of 10 years prior, and in her second pregnancy, 
proved to be “at risk.” Hemolytic disease of the 
fetus and newborn is characterized by the destruc-
tion of fetal and newborn red cells by maternal allo-
antibodies specific for inherited paternal red cell 
alloantigen. The rate of hemolysis and severity of 
disease are determined by maternal IgG subclass, the 
amount of placental and circulating antibody, and 
the number of antigenic sites that exist on the 
affected red cells.8) Generally, HDFN caused by 
anti-Dib has been considered to be associated with 
mild to non-existent hemolysis9-11) although previous 
reports of Dib-related HDFN strongly suggest that 
the severity of this disease varies considerably, ran-
ging from no symptoms to severe jaundice requiring 
exchange transfusion (ET).
Mochizuki, et al., only a few years ago reported 
a significant correlation between maternal anti-Dib 
titer and the severity of disease in the fetus and new-
born. In this study,3) it was discovered that, among 
reported cases, approximately 60% of affected babies 
born to mothers having an anti-Dib titer of 64 or 
greater needed ET and/or high dose intravenous im-
munoglobulin (IVIG). In our case, a highly elevated 
maternal titer of anti-Dib (256) was associated with 
elevated risk of severe hyperbilirubinemia in the 
mismatched newborn. Thus, having prior awareness 
in mothers of excess paternal antigen should compel 
researchers and clinicians to determine the likely 
severity of peri- and postnatal disease, particularly 
HDFN and its ramifications.
  Concerning treatment for severe cases, phototherapy, 
ET, or both, have routinely been performed. In most 
cases it has proven difficult to obtain the necessary 
Di(b-) RBCs needed for effective transfusion. Be-
cause the Di(b-) blood group phenotype is very rare, 
the authors were not surprised to find that of 600 
crossmatch tests run on cross-matched blood ob-
tained from our regional center, compatible Di(b-) 
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Table 1. Reported cases of HDFN due to anti-Dib in Korea
Year
reported
Pregnancy 
Hx
Trans-
fusion
Hx
Ab screening
test in 
antenatal care
Anti-Dib
titer
Diego
blood
type of
newborn
Treatment
for newborn
Jaundice
at birth
Hb level
(g/dL)
T. bil
level
(mg/dL)
Reference
No.
1994 G3P1 + NT NT Di(a+b+) Transfusion + 5.2 (ND7) 13.6 (ND7) 5
1999 G3P2 + NT NT Di(a+b+) ET+transfuion + 7.8 (ND3) 20.0 (ND3) 6
2008 G2P0 + NT 1,024 Di(a+b+) Phototherapy
+IVIG
+ 8 (ND3) 16.1 (ND3) 4
This case G2P1 + Anti-Dib
was detected
256 Di(a+b+) Phototherapy − 17.2 (ND4) 9.7 (ND4) 　
Abbreviations: ND, neonatal day; Hb, hemoblogin; T. bil, total bilirubin; ET, exchange transfusion; NT, not tested; Hx, 
history; Ab, antibody.
RBCs were found but once! So, in search of greater 
supplies of compatible rare blood, KRC is currently 
testing numerous units randomly selected from the 
complete array of our holdings in storage − a 
procedure that is usually time intensive and occa-
sionally even fruitless. In our case, it was also very 
difficult to find compatible Di(b-) blood: among 600 
O+ blood units randomly selected, once again only 
one turned out to be compatible. There was no need 
for transfusion because the HDFN due to anti-Dib 
was mild, But based on our experience that to find 
compatible Di(b-) blood is very difficult, We 
concluded that a donor-registration system which 
notates rare blood types should be established at the 
national level if such disease-defeating blood is to 
be effectively and safely employed. This study pro-
vides further support to previous research in which 
we advocated for the registration and collection of 
rare blood types via emergency donation, parti-
cularly and especially when such donors can be 
identified and/or pre-screened.12)
  Table 1 summarizes three previous reports relative 
to anti-Dib related HDFN in Korea. As noted, while 
HDFN due to the anti-Dib is often associated with 
very mild hemolysis, three previous cases in Korea 
showed up the potential for severe hemolytic conse-
quences and hyperbilirubinemia serious enough to 
require IVIG and/or ET. Unlike these previous cases, 
our patient displayed no obvious hemolysis and 
presented with a mildly increased total bilirubin. 
Indeed, our case resembled those of Habash et al10) 
and Lenkiewicz and Zupanska11) in that a strongly 
positive infant DAT was present, yet without 
observable signs of hemolysis. Another important 
difference between historical Korean cases and the 
present one is that anti-Dib detection through 
antenatal screening was uniquely here performed. 
Generally, after newborns have shown signs of 
anemia and/or hyperbilirubinemia, anti-Dib is de-
tected − and typically as a function of hemolysis 
evaluation. A critical insight then into this disease 
cluster, and what can be done about it preventa-
tively, organizes itself around proper periodic ante-
natal screening. For patients with irregular anti-
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bodies, as we show here, can readily be detected, 
and their attending physicians can be alert as to 
potential hemolytic problems in the immediate fu-
ture, thus providing crucial laboratories with the 
valuable time they need to find, and best utilize, 
acceptable donors. Koelewijn et al13) evaluated the 
effect of a first trimester antibody screening program 
on the timely detection of HDFN caused by anti-
bodies other than anti-D. They conclude that a single 
first-trimester RBC alloantibody screen detects the 
important health problem of severe HDFN and 
screening program seems justified as part of routine 
prenatal care.13) On the other hand, There was an-
other suggestion about the clinical significance of 
prenatal antibody screening test. Chung et al suggest 
that routine prenatal antibody screening may not be 
necessary for all pregnant women except Rh(D) 
negative women or those who have a history of 
HDN. Because among the positive results of anti-
body screening test, no one had evidence of HDN 
in their study.14)
Summary
  Di(a+b-) 혈액형을 가진 사람만이 혈청에 항- 
Dib를 생산할 수 있지만 이런 혈액형은 백인에서
는 매우 드물며, 대부분 몽고인종에 국한되어 나
타난다. 세계적으로 항-Dib가 신생아용혈성질환
을 유발한다는 보고는 있지만 이에 대한 임상적 
의의는 확실히 확립되어 있지 않다. 저자들은 임
신 15주째 산전관리를 받던 산모에서 항-Dib를 검
출하였고 고빈도 항원에 대한 항체인 경우 적합
한 혈액을 구하는 것이 쉽지 않을 뿐 아니라 그 
항체에 의한 신생아용혈성질환의 발생 여부도 예
측할 수 없는 상태에서 교환수혈을 위한 O형 
Di(a+b-)를 준비하려고 하였다. 대한적십자사 중
앙 혈액검사센터에서 산모의 혈청과 600단위의 
O형 농축적혈구와 교차시험을 시행하였고 한단
위의 적합 혈액을 찾을 수 있었다. 또한 B형인 산
모로부터 2단위의 혈액을 자가혈액으로 예치하
여 준비하였다. 태어난 환아는 Di(a+b+) 혈액형이
었지만 경미한 신생아용혈성질환을 보였을 뿐 광
선요법만으로 호전되어 교환수혈 없이 퇴원하였
다. 국내에서 이미 보고된 항-Dib 검출 3예는 신생
아용혈성질환이 의심되는 환아에서 분만 후 산모
의 혈청에서 검출된 증례였다. 본 증례는 산전관
리에서 발견되어 6개월 동안 Di(b-) 혈액을 혈액
은행에서 수혈용 혈액과 교환수혈용 혈액을 준비
하는 과정의 경험을 국내의 첫 증례로 보고하면
서 국내에서도 희귀혈액에 대한 헌혈자 등록제의 
필요성을 제안하고자 한다.
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